Igene Biotechno (IGNE) Stock Price, News & Analysis

Company Overview

Igene Biotechnology, Inc. (OTCMKTS: IGNE) is a biotechnology company focused on developing and commercializing natural ingredients for nutritional, food, cosmetic and animal-health applications.

The company has been associated with the production and development of natural astaxanthin, a carotenoid commonly used as an antioxidant ingredient in dietary supplements, functional foods, cosmetics and animal nutrition products. Its activities have included biotechnology and fermentation-based research intended to support the manufacture of naturally derived compounds.

Publicly available information about Igene Biotechnology’s current operations, geographic markets and leadership is limited. Accordingly, details about its present product portfolio and management team cannot be confirmed reliably.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:IGNE
• CIK: N/A
• Web: www.igene.com
• Phone: (410) 997-2599
• Fax: 410-997-1392
• Employees: 18
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A